Congressman Eric Swalwell Awards Cerebrotech Medical Systems Special Congressional Recognition for Innovation and Economic Growth

PLEASANTON, Calif.–(BUSINESS WIRE)–Cerebrotech
Medical Systems
, an innovative medical device company focused on the
development of a portable brain bioimpedance monitor, has received a
Special Congressional Recognition by U.S. Congressman Eric Swalwell for
achieving the 2017 “Economic Driver” award from the Chamber of Commerce
of Pleasanton, CA, where the neurotechnology solution company is located.

“Congratulations to Cerebrotech for achieving this award. I am very
proud of the great innovation taking place here in Pleasanton at
groundbreaking startup medical device companies like Cerebrotech,” said
Pleasanton Mayor Jerry Thorne. “These companies are developing
revolutionary technologies that will make important advances for the
future of medical care.”

“Cerebrotech’s innovative technology has the ability to drastically
change the paradigm of care for patients at high risk of stroke and
brain damage, and we are honored to be recognized for the company’s
potential impact in our hometown,” remarked Cerebrotech’s Medical
System’s Chief Executive Officer, Mitch Levinson. “Cerebrotech is the
third medical device company I have been fortunate enough to help start
right here in Pleasanton. These companies have been able to take
advantage of the innovative infrastructure of the Bay Area, and tap into
the pool of technical employees who enjoy the more balanced lifestyle of
the Tri-Valley cities like Pleasanton.”

Cerebrotech’s technological innovation is focused on creating and
commercializing a portable brain bioimpedance monitor. This monitor is
being designed to improve outcomes for stroke patients by providing
real-time assessments critical to assessment and recovery.
Implementation of its core technology, Volumetric Integral Phase-shift
Spectroscopy (VIPS™), will allow for earlier intervention, and reduce
recovery time and hospital costs. Using Cerebrotech’s proprietary
machine learning technology, the company plans to train its wireless,
portable Intracranial Fluids Monitor™ to detect a variety of
neurological conditions, including stroke, cerebral edema, traumatic
brain injury, hydrocephalus, concussion and brain tumors non-invasively.
The device holds a CE Mark, and is not yet cleared for sale in the
United States.

About Cerebrotech Medical Systems

Cerebrotech
Medical Systems
, Inc., is a venture capital-backed company dedicated
to designing neurotechnology solutions to improve the care of
brain-injured patients worldwide. The company is developing a portable,
noninvasive neuro-monitoring device that allows for earlier detection of
potentially life-threatening conditions such as large vessel occlusion
stroke, cerebral edema, traumatic brain injury, and others. Founded in
2010 and based in Pleasanton, CA, Cerebrotech’s core intellectual
property is licensed exclusively from the University of California at
Berkeley. Cerebrotech is backed by Tri-Star Health Partners, a
healthcare focused venture capital firm, Mountain Group Partners, a life
sciences and technology focused venture capital firm, Neuro Technology
Investors, a group of physician investors in the neuro space. For more
information, visit www.cerebrotechmedical.com.

Contacts

For Cerebrotech Medical Systems, Inc.
Tara DiMilia, 908-369-7168
tara.dimilia@tmstrat.com